《Journal Of Managed Care & Specialty Pharmacy》雜志的收稿范圍和要求是什么?
來(lái)源:優(yōu)發(fā)表網(wǎng)整理 2024-09-18 11:09:52 258人看過(guò)
《Journal Of Managed Care & Specialty Pharmacy》雜志收稿范圍涵蓋醫(yī)學(xué)全領(lǐng)域,此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊,在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大,專業(yè)度認(rèn)可很高,所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高,如果您的文章質(zhì)量很高,可以嘗試。
平均審稿速度 ,影響因子指數(shù)2.3。
該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
具體收稿要求需聯(lián)系雜志社或者咨詢本站客服,在線客服團(tuán)隊(duì)會(huì)及時(shí)為您答疑解惑,提供針對(duì)性的建議和解決方案。
出版商聯(lián)系方式:100 N PITT ST, 400, ALEXANDRIA, USA, VA, 22314-3134
其他數(shù)據(jù)
是否OA開(kāi)放訪問(wèn): | h-index: | 年文章數(shù): |
未開(kāi)放 | 55 | 128 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來(lái)源于搜索引擎): | 開(kāi)源占比(OA被引用占比): |
0.71% | 2.3 | 0.00... |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
93.75% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年中科院JCR大類分區(qū)數(shù)據(jù):
歷年自引數(shù)據(jù):
發(fā)文統(tǒng)計(jì)
2023-2024國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì):
國(guó)家/地區(qū) | 數(shù)量 |
USA | 494 |
Canada | 24 |
England | 24 |
GERMANY (FED REP GER) | 6 |
Switzerland | 6 |
Denmark | 5 |
Ireland | 4 |
Japan | 4 |
Australia | 3 |
Belgium | 3 |
2023-2024機(jī)構(gòu)發(fā)文量統(tǒng)計(jì):
機(jī)構(gòu) | 數(shù)量 |
UNIVERSITY OF WASHINGTON | 32 |
KAISER PERMANENTE | 28 |
UNIVERSITY OF CALIFORNIA SYSTEM | 28 |
HARVARD UNIVERSITY | 21 |
UNIVERSITY OF TEXAS SYSTEM | 20 |
JOHNSON & JOHNSON | 19 |
US DEPARTMENT OF VETERANS AFFAIR... | 19 |
NOVARTIS | 18 |
PENNSYLVANIA COMMONWEALTH SYSTEM... | 18 |
UTAH SYSTEM OF HIGHER EDUCATION | 18 |
近年引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
J MANAG CARE SPEC PH | 195 |
NEW ENGL J MED | 158 |
VALUE HEALTH | 123 |
J CLIN ONCOL | 80 |
AM J MANAG CARE | 72 |
DIABETES CARE | 72 |
JAMA-J AM MED ASSOC | 72 |
HEALTH AFFAIR | 59 |
MED CARE | 58 |
ANN RHEUM DIS | 41 |
近年被引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
J MANAG CARE SPEC PH | 195 |
J AM PHARM ASSOC | 42 |
J MED ECON | 32 |
CURR MED RES OPIN | 28 |
ADV THER | 26 |
AM J HEALTH-SYST PH | 24 |
PATIENT PREFER ADHER | 22 |
BMJ OPEN | 19 |
VALUE HEALTH | 19 |
AM HEALTH DRUG BENEF | 18 |
近年文章引用統(tǒng)計(jì):
文章名稱 | 數(shù)量 |
Higher Incidence Rates of Comorb... | 20 |
Factors Affecting Health Care Pr... | 16 |
Optimizing Anti-VEGF Treatment O... | 16 |
Burden of Illness in Type 2 Diab... | 15 |
Gene Therapy for Spinal Muscular... | 13 |
The Biosimilar Nocebo Effect? A ... | 13 |
Cost-Effectiveness of Ribociclib... | 12 |
Serious Adverse Drug Events Repo... | 11 |
Integrating Innovative Telehealt... | 10 |
Real-World Analysis of Dispensed... | 10 |
聲明:以上內(nèi)容來(lái)源于互聯(lián)網(wǎng)公開(kāi)資料,如有不準(zhǔn)確之處,請(qǐng)聯(lián)系我們進(jìn)行修改。